Kenneth V. Honn

Q: What Schools Are Affiliated With Kenneth V. Honn

Kenneth V. Honn is affiliated with the following schools: Wayne State University

Kenneth V. Honn's AcademicInfluence.com Rankings

Kenneth V. Honn

Biology

#7934

World Rank

#10932

Historical Rank

Biochemistry

#1118

World Rank

#1235

Historical Rank

biology Degrees

Download Badge

Biology

Kenneth V. Honn's Degrees

PhD Biochemistry University of California, San Francisco
Bachelors Chemistry University of California, Berkeley

Why Is Kenneth V. Honn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kenneth V. Honn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. (1992) (425)
Lysosomal cathepsin B: correlation with metastatic potential. (1981) (384)
Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. (1996) (351)
Prostacyclin: a potent antimetastatic agent. (1981) (346)
Cyclooxygenases, prostanoids, and tumor progression (2007) (339)
Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. (1981) (288)
Lipoxygenase metabolism: roles in tumor progression and survival (2007) (287)
Platelets and cancer: a casual or causal relationship: revisited (2014) (242)
Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. (2002) (241)
Platelets and cancer metastasis: A causal relationship? (1992) (236)
Cathepsin B: association with plasma membrane in metastatic tumors. (1986) (225)
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. (1982) (220)
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. (1995) (210)
Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. (1998) (180)
Fetal Bovine Serum: A Multivariate Standard 1 (1975) (174)
Thromboxane A2 Regulation of Endothelial Cell Migration, Angiogenesis, and Tumor Metastasis☆ (2000) (172)
Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. (1989) (172)
Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. (1988) (168)
Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid* (2011) (163)
Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. (1983) (157)
Platelets and cancer angiogenesis nexus (2017) (157)
Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. (1985) (156)
Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. (2003) (156)
Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. (1993) (154)
Cyclooxygenase, lipoxygenase and tumor angiogenesis (2002) (151)
Platelets and cancer metastasis: more than an epiphenomenon. (1992) (148)
Interactions of cancer cells with the microvasculature during metastasis 1 2 (1988) (148)
12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis (1994) (142)
Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. (2000) (137)
Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. (1994) (136)
Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. (1994) (127)
Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)‐HETE‐induced endothelial cell retraction (1989) (124)
Thrombin increases the metastatic potential of tumor cells (1993) (122)
Platelet “first responders” in wound response, cancer, and metastasis (2017) (121)
Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix (1992) (120)
Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. (1991) (116)
Corticosteroids in serum of Rana catesbeiana during development and metamorphosis. (1983) (114)
Adhesion molecules and tumor metastasis: an update. (1994) (113)
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. (1995) (113)
A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. (1994) (113)
12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. (1994) (113)
12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. (1995) (112)
Role of Eicosanoids in Prostate Cancer Progression (2004) (110)
Mechanisms Regulating Tumor Angiogenesis by 12-Lipoxygenase in Prostate Cancer Cells* (2006) (109)
12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. (1995) (109)
Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis (2015) (104)
Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell‐platelet and tumor cell‐matrix interactions (1988) (98)
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. (2000) (96)
Inflammation and disease progression (2006) (95)
Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: Role of 12‐lipoxygenase in regulating tumor cell survival (1997) (93)
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis (2011) (91)
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. (2004) (91)
The lipoxygenase metabolite 12(S)‐hete induces a cytoskeleton‐dependent increase in surface expression of integrin αiibβ3 on melanoma cells (1991) (90)
Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandins (1985) (90)
Regulation of melanoma‐cell motility by the lipoxygenase metabolite 12‐(S)‐hete (1993) (89)
Solid tumor cells express functional "tethered ligand" thrombin receptor. (1995) (88)
Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. (1993) (86)
Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. (1982) (85)
Expression, subcellular localization and putative function of platelet‐type 12‐lipoxygenase in human prostate cancer cell lines of different metastatic potential (2000) (84)
Membrane-associated cathepsin L: a role in metastasis of melanomas. (1989) (84)
Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. (1984) (82)
Emerging technology: applications of Raman spectroscopy for prostate cancer (2014) (77)
Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. (1987) (76)
Platelet‐type 12‐lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF‐κB (2013) (76)
Plasma membrane-associated cysteine proteinases in human and animal tumors. (1987) (76)
Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. (1988) (76)
Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor (2014) (75)
Apoptosis: a general comment (1991) (75)
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants. (1994) (74)
Nafazatrom (bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation (1982) (73)
Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. (1994) (71)
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho. (2008) (71)
Diagnostic and prognostic markers for human prostate cancer (1997) (70)
Eicosanoid Activation of Extracellular Signal-regulated Kinase1/2 in Human Epidermoid Carcinoma Cells* (2000) (70)
Effects of prostacyclin on tumor cell-induced platelet aggregation. (1984) (70)
Thromboxanes and prostacyclin: positive and negative modulators of tumor growth. (1981) (69)
Cysteine proteinases and metastasis (2004) (68)
Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase (2004) (68)
12(S)‐hete promotes tumor‐cell adhesion by increasing surface expression of αVβ3 integrins on endothelial cells (1993) (67)
The lipoxygenase metabolite 12(S)‐hete promotes αllbβ3integrin‐mediated tumor‐cell spreading on fibronectin (1992) (67)
The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. (1993) (65)
Thrombin enhances tumor cell adhesive and metastatic properties via increased αIIbβ3 expression on the cell surface (1992) (65)
Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. (1989) (65)
Ectopic expression of platelet integrin αIIbβ3 in tumor cells from various species and histological origin (1997) (65)
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis (1989) (64)
Transcriptional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE. (1995) (64)
Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. (1994) (64)
12‐Lipoxygenase, 12(S)‐HETE, and Cancer Metastasis a (1994) (62)
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. (1997) (62)
Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: effects on metastatic potential. (1992) (62)
Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis (2016) (62)
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5 (2012) (59)
Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process. (1994) (59)
Role of Tumor Cell Cytoskeleton and Membrane Glycoprotein IRGpIIb/IIIa in Platelet Adhesion to Tumor Cell Membrane and Tumor Cell-induced Platelet Aggregation (1988) (59)
Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor (1993) (58)
Identification of 12-lipoxygenase interaction with cellular proteins by yeast two-hybrid screening. (2000) (58)
Degradation of laminin by human tumor cathepsin B (1989) (58)
Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. (1985) (58)
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents. (1979) (57)
Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. (1995) (57)
Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. (1990) (57)
Identification of the alpha IIb beta 3 integrin in murine tumor cells. (1992) (55)
Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis. (1992) (55)
Activity and protein distribution of 12-lipoxygenase in HEL cells: induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca(2+)-dependent translocation to membranes. (1993) (53)
The High Affinity αIIbβ3 Integrin Is Involved in Invasion of Human Melanoma Cells (1997) (52)
Role of αIIbβ3 integrin in prostate cancer metastasis (1998) (51)
Role for β3 integrins in human melanoma growth and survival (2002) (51)
Enhanced levels of cathepsin B mRNA in murine tumors (1989) (51)
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors. (1984) (50)
Increased expression of αIIb β3 integrin in subpopulations of murine melanoma cells with high lung‐colonizing ability (1992) (50)
αIIbβ3 Integrin expression and function in subpopulations of murine tumors (1992) (49)
Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix. (1987) (49)
Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. (2012) (49)
Protein‐kinase‐C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization (1992) (49)
Inhibition of Human Tumor Cell Induced Platelet Aggregation by Antibodies to Platelet Glycoproteins lb and llb/llla (1987) (48)
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. (1996) (48)
Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells. (2013) (47)
12(S)-HETE in cancer metastasis. (1999) (47)
The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation. (1987) (47)
Lipoxygenase Products Regulate IRGpllb/llla Receptor Mediated Adhesion of Tumor Cells to Endothelial Cells, Subendothelial Matrix and Fibronectin (1988) (47)
PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells. (1993) (46)
12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells. (2010) (45)
Studies on the role of platelet eicosanoid metabolism and integrin αIIbβ3 in tumor‐cell‐induced platelet aggregation (1993) (45)
Platelet-type 12-lipoxygenase activates NF-κB in prostate cancer cells (2003) (44)
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids (1997) (43)
Human Prostate Carcinoma Cells Express Functional αIIbβ3 Integrin (1996) (43)
Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575). (1982) (43)
Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity. (1985) (43)
Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past? (2017) (42)
An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions. (1990) (42)
In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II). (1989) (42)
Eicosanoid regulation of angiogenesis in tumors. (2004) (41)
12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and αVβ3 integrins (1993) (41)
Prostaglandin Analogs as Inhibitors of Tumor Cell DNA Synthesis 1 (1981) (41)
Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome[S] (2016) (40)
The β4 Integrin Subunit Rescues A431 Cells from Apoptosis through a PI3K/Akt Kinase Signaling Pathway (1999) (40)
Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up‐regulation of leukotriene B4 (2016) (40)
Synthesis of peptide-diazeniumdiolate conjugates: towards enzyme activated antitumor agents (2001) (39)
Lipoxygenase regulation of membrane expression of tumor cell glycoproteins and subsequent metastasis. (1989) (39)
Eicosanoids and Other Bioactive Lipids in Cancer and Radiation Injury (1991) (39)
A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells (1992) (39)
Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells (2004) (39)
Prostacyclin and its analogues: antimetastatic effects and mechanisms of action (1994) (38)
Prostaglandin modulation of the mechanism of ACTH action in the human adrenal. (1976) (38)
Multiple use of a signal transduction pathway in tumor cell invasion. (1996) (38)
Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. (1992) (37)
Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. (1997) (37)
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners (2021) (36)
Immunomorphological characterization and effects of 12-(S)-HETE on a dynamic intracellular pool of the alpha IIb beta 3-integrin in melanoma cells. (1995) (36)
Utility of ozone treatment in the maintenance of water quality in a closed marine system (1976) (35)
Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases. (1986) (35)
Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. (1987) (34)
Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase. (2000) (34)
12-Lipoxygenase in A431 cells: genetic identity, modulation of expression, and intracellular localization. (1996) (33)
Melanoma cell spreading on fibronectin induced by 12(S)‐HETE involves both protein kinase C‐ and protein tyrosine kinase‐dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK) (1995) (32)
Radiosensitivity of human prostate cancer cells can be modulated by inhibition of 12-lipoxygenase. (2013) (32)
Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. (1987) (31)
12(S)‐hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: A protein kinase‐dependent process (1998) (31)
12(S)-HETE, pleiotropic functions, multiple signaling pathways. (2002) (31)
A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. (1987) (31)
Ectopic αIIbβ3 Integrin Signaling Involves 12-Lipoxygenaseand PKC-mediated Serine Phosphorylation Events in Melanoma Cells (2001) (30)
Eicosanoids in tumor progression and metastasis. (2008) (30)
Role for cathepsin B and cystatins in tumor growth and progression. (1990) (29)
Cathepsin B-like activity in viable tumor cells isolated from rodent tumors. (1985) (29)
Role of prostaglandins in aldosterone production by the human adrenal. (1976) (28)
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. (1997) (28)
Mechanisms of Cancer Metastasis (1986) (28)
Analysis of integrin mRNA in human and rodent tumor cells. (1991) (28)
Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane. (1987) (28)
An improved automated Biuret method for the determination of microgram protein concentrations. (1975) (27)
Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions (2004) (27)
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor. (1994) (27)
High-frequency of loss of expression and allelic deletion of the apc and mcc genes in human prostate-cancer. (1995) (27)
12-lipoxygenase expression in human melanoma cell lines. (1999) (27)
Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis. (1983) (26)
12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes. (1995) (26)
Hemostatic Mechanisms and Metastasis (2011) (26)
12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha. (1997) (25)
Role of alphaII(b)beta3 integrin in prostate cancer metastasis. (1998) (25)
Calcium Channel Blockers: Potential Antimetastatic Agents (1983) (25)
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15‐lipoxygenase‐2 in prostate cancer (2009) (24)
Separation of High and Low Metastatic Subpopulations from Solid Tumors by Centrifugal Elutriation (1988) (24)
Arachidonic acid metabolism of cytosolic fractions of Lewis lung carcinoma cells. (1991) (24)
Eicosanoid Regulation of Angiogenesis in Human Prostate Carcinoma and Its Therapeutic Implications (2000) (24)
Role for beta3 integrins in human melanoma growth and survival. (2002) (24)
Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization. (1997) (23)
12‐HETER1/GPR31, a high‐affinity 12(S)‐hydroxyeicosatetraenoic acid receptor, is significantly up‐regulated in prostate cancer and plays a critical role in prostate cancer progression (2016) (23)
ETS-1-mediated Transcriptional Up-regulation of CD44 Is Required for Sphingosine-1-phosphate Receptor Subtype 3-stimulated Chemotaxis* (2013) (23)
In vitro tropic action of ACTH upon adrenocortical cyclic nucleotide (cAMP, cGMP) production and corticosterone output in blue (Prionace glauca Linnaeus) and in mako (Isurus oxyrinchus Rafinesque) sharks. (1978) (23)
Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner (2015) (23)
Fatty acid modulation of tumor cell-platelet-vessel wall interaction (1992) (22)
The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells. (1991) (22)
Phenotypic properties of cultured tumor cells: Integrin αIIbβ3 expression, tumor‐cell‐induced platelet aggregation, and tumor‐cell adhesion to endothelium as important parameters of experimental metastasis (1993) (22)
Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment (2011) (21)
HLA-DR is a procoagulant. (1991) (21)
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin αIIbβ3 and tumor-cell-induced platelet aggregation (2005) (21)
Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. (1993) (20)
Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. (1983) (20)
Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. (2003) (20)
Significance of SHP-1 and SHP-2 Expression in Human Papillomavirus Infected Condyloma acuminatum and Cervical Cancer (2008) (20)
Overexpression of Platelet-type 12-Lipoxygenase Promotes Tumor Cell Survival by Enhancing v 3 and v 5 Integrin Expression 1 (2003) (20)
Temporal effect of prostaglandins E and F on human adrenal cAMP and cortisol output. (1978) (20)
Inhibition of TPA and 12(S)‐HETE‐stimulated tumor cell adhesion by prostacyclin and its stable analogs: Rationale for their antimetastatic effects (2006) (20)
The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway. (1999) (19)
A review of prostaglandins and the treatment of tumor metastasis. (1983) (19)
Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor. (1988) (19)
ACTH control of adrenocortical c-GMP ☆ (1975) (19)
Parallel expression of αIIbβ3 and αvβ3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype (2005) (19)
12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and alpha V beta 3 integrins. (1993) (19)
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells. (2001) (19)
Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation. (1988) (18)
Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. (1985) (18)
The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells. (1997) (18)
Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin. (1996) (17)
Emerging targets in lipid-based therapy. (2013) (17)
Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner. (2016) (17)
Is there a role for the tumor cell integrin αIIbβ3 and cytoskeleton in tumor cell-platelet interaction? (1992) (16)
Bioactive lipid metabolism in platelet “first responder” and cancer biology (2018) (16)
Biological properties of 12(S)-HETE in cancer metastasis. (1995) (16)
Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm (2020) (16)
Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination (2019) (16)
Tumor cathepsin B and its endogenous inhibitors in metastasis. (1988) (15)
Erratum: 12(S)-Hydroxyeicosatetraenoic acid and 13(S)- hydroxyoctadecadienoic acid regulation of protein kinase C-α in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids (Cell (September 26, 1995) 92:20 (9323-9327)) (1995) (15)
Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles (1983) (15)
Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction? (1992) (15)
Cooxidation of 13-cis-retinoic acid by prostaglandin H synthase. (1984) (15)
Platelet-Tumor Cell Interactions as a Target for Antimetastatic Therapy (1986) (15)
The lipoxygenase metabolite 12(S)-HETE promotes alpha IIb beta 3 integrin-mediated tumor-cell spreading on fibronectin. (1992) (14)
Effects of A and B series prostaglandins on cAMP, cortisol and aldosterone production by the human adrenal (1977) (14)
Adrenocortical ultrastructure in the squaliform elasmobranch (Ginglymostoma cirratum Bonnaterre): cell death, a postulate for holocrine secretion. (1975) (14)
A naturally occurring truncated β3 integrin in tumor cells: Native anti-integrin involved in tumor cell motility (2007) (13)
Identification of a Novel Truncated αIIb Integrin (1998) (13)
Accurate identification of breast cancer margins in microenvironments of ex-vivo basal and luminal breast cancer tissues using Raman spectroscopy. (2020) (13)
Prototype design for a closed marine system employing quarternary water processing (1975) (13)
Loss of Heterozygosity of the BRCA 1 and Other Loci on Chromosome 17 q in Human Prostate Cancer (2006) (13)
Increased expression of alpha IIb beta 3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability. (1992) (13)
The role of eicosanoids in tumor growth and metastasis. (2000) (13)
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effectsin vitro andin vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases (1998) (12)
Hemostasis and malignancy: an overview (1992) (12)
Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine (2004) (12)
Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions (1984) (12)
Expression and function of the high affinity αIibβ3 integrin in murine melanoma cells (1998) (12)
In vitro temporal cAMP and cortisol responses to ACTH by the normal human adrenal gland. (1977) (12)
Prostacyclin/Thromboxanes and Tumor Cell Metastasis (1984) (11)
Alpha IIb beta 3 integrin expression and function in subpopulations of murine tumors. (1992) (11)
Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype. (2005) (10)
Adhesion molecules and site-specific metastasis (1992) (10)
Effects of 12-Hydroxyeicosatetraenoic Acid on Release of Cathepsin B and Cysteine Proteinase Inhibitors from Malignant Melanoma Cells (1991) (10)
Identification of a novel truncated alphaIIb integrin. (1998) (10)
PROSTAGLANDINS, LEUKOTRIENES, AND CANCER (1985) (10)
Overexpression of leukocyte‐type 12‐lipoxygenase promotes W256 tumor cell survival by enhancing αvβ5 expression (2003) (10)
Platelet-type 12-lipoxygenase regulates angiogenesis in human prostate carcinoma. (1999) (10)
Association of protein kinase-C-alpha with cytoplasmic vesicles in melanoma cells. (1996) (10)
4 – Prostaglandin, Thromboxane, and Leukotriene Biosynthesis: Target for Antitumor and Antimetastatic Agents (1984) (9)
Ozonation as a Critical Component Of Closed Marine System Design (1979) (9)
12(S)-Hete-Induced Microvascular Endothelial Cell Retraction is Mediated by Cytoskeletal Rearrangement Dependent on PKC Activation (1993) (9)
12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cells. (1993) (9)
Critical role of arachidonate lipoxygenases in regulating apoptosis. (1997) (9)
In vitro ACTH stimulation of corticosterone output in relation to cyclic nucleotide alterations in the crocodilian (Caiman sclerops) adrenal. (1977) (8)
A high capacity ozone generator for use in aquaculture and water processing (1976) (8)
Key determinants of the invasion mechanism of melanoma. Role for a new signaling pathway. (1997) (8)
Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy (2020) (8)
Lipoxygenase metabolites and cancer metastasis. (1997) (8)
Immunomorphological characterization and effects of 12-( S )-HETE on a dynamic intracellular pool of the α IIb β 3-integrin in melanoma cells (1995) (8)
Tumor cysteine proteinases and their inhibitors (1986) (8)
The Lipoxygenase Metabolite of Arachidonic Acid, 12-(S)-Hete, Induces Cytoskeleton Dependent Upregulation of Integrin αIIbβ3 in Melanoma Cells (1991) (8)
Analysis of Platelet, Tumor Cell and Endothelial Cell Interactions in Vivo and in Vitro (1987) (7)
Control of Tumor Cell Induced Endothelial Cell Retraction by Lipoxygenase Metabolites, Prostacyclin and Prostacyclin Analogues (1991) (7)
Tumor suppressor genes and their involvement in human prostate cancer (1995) (7)
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation. (1992) (7)
It is not just the drugs that matter: the nocebo effect (2019) (7)
CHAPTER 18 – PROSTAGLANDINS IN TUMOR CELL METASTASIS (1985) (7)
The role of platelets in metastasis. (1987) (7)
Prostacyclin, thromboxanes, and hematogenous metastasis. (1983) (7)
Role of 12-Lipoxygenase and Protein Kinase C in Modulating the Activation State of the Integrin αIIbβ3 on Human Tumor Cells (1997) (6)
cAMP involvement in the control of corticosterone and aldosterone output in the adrenal of the frog (Rana berlandieri forreri) (1978) (6)
The Effects of Eicosanoid Inhibitors on Tumor Cell Arachidonic Acid (and Metabolite) Uptake, Release and Metabolism (1987) (6)
Cathepsin B-Like Cysteine Proteinases and Metastasis (1986) (6)
Eicosanoid 12(S)-HETE upregulates endothelial cell α(V)β3 integrin expression and promotes tumor cell adhesion to vascular endothelium (1997) (6)
Role of 12-Lipoxygenase Metabolites and Integrin Glycoprotein Receptors in Metastasis (1990) (6)
Convergence of eicosanoid and integrin biology: Role of Src in 12‐LOX activation (2017) (6)
Role of Tumour Cell Eicosanoids and Membrane Glycoproteins IRGPIb and IRGPIIb/IIIa in Metastasis (1988) (6)
Eicosanoid 12(S)-HETE upregulates endothelial cell alpha V beta 3 integrin expression and promotes tumor cell adhesion to vascular endothelium. (1997) (6)
The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases (2019) (6)
Overexpression of leukocyte-type 12-lipoxygenase promotes W256 tumor cell survival by enhancing alphavbeta5 expression. (2003) (6)
Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis (1984) (6)
Regulation of 12(S)-HETE production in tumor cells. (1997) (6)
Thromboxane synthetase inhibitors and prostacyclin can control tumor cell metastasis (1980) (6)
Eicosanoid Regulation of Tumor Cell-Platelet and -Endothelium Interaction During Arrest and Extravasation (1993) (6)
Possible strategies for antimetastastic therapy. (1986) (6)
In vitro responses of focal hyperplastic tissue of the human adrenal zona fasciculata to ACTH. (1977) (6)
Regulation of tumor cell motility by 12(S)-HETE. (1997) (6)
Prostate cancer old problems and new approaches (1996) (5)
Eicosanoids, cancer metastasis, and gene regulation: an overview. (1997) (5)
Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells. (1998) (5)
Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects). (1996) (5)
[Selective 12-lipoxygenase inhibition potentiates the effect of radiation on human prostate cancer cells in vitro and in vivo]. (2014) (5)
Prostate Cancer Old Problems and New Approaches (1996) (5)
Post-translational regulation of surface integrin expression in tumor cells by 12(S)-HETE. (1997) (5)
Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy (2021) (5)
Overview of articles on eicosanoids and cancer (1994) (5)
Diary of events (1999) (5)
Hematological responses to thermal acclimation in a cold water squaliform (Heterodontus francisci girard) (2004) (5)
In vitro effects of theophylline and aminogluthetimide upon basal and ACTH induced cAMP levels and steroid output by the normal human adrenal gland. (1978) (5)
Role of autocrine motility factor in a 12-lipoxygenase dependent anti-apoptotic pathway. (1999) (5)
Prostaglandin effects upon cyclic AMP levels, corticosterone output, and aldosterone output in the adrenal of the frog, Rana berlandieri forreri. (1978) (5)
Lipoxygenases, Integrin Receptors, and Metastasis (1991) (5)
Nafazatrom (BAY g 6575): Inhibitor of tumor cell proliferation and metastasis (1982) (4)
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies. (1999) (4)
12-(S)-HETE Induces Cytoskeleton Phosphorylations and Rearrangement in Melanoma Cells (1993) (4)
Emerging technology: applications of Raman spectroscopy for prostate cancer (2014) (4)
Cytochrome P-450 and adrenodoxin in adrenal mitochondrial fractions of several lower vertebrates. (1976) (4)
Prostate Cancer: New Horizons in Research and Treatment (2002) (4)
Proteolytic Enzymes and Arachidonic Acid Metabolites (1985) (4)
Sphingosine-1-phosphate receptor-3 signaling upregulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells (2012) (4)
Mitochondrial redox components of human adrenocortical steroid hydroxylases under physiological conditions and in focal hyperplasia of the zone fasciculata. (1977) (3)
Applications for Antimetastatic Therapies (1986) (3)
Role of 12-lipoxygenase and protein kinase C in modulating the activation state of the integrin alpha IIb beta 3 on human tumor cells. (1997) (3)
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective (2022) (3)
Prostaglandins and Immunity (1985) (3)
Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients (2022) (3)
Clinical and experimental morphologic parameters predictive of tumor metastasis. (1986) (3)
In vitro trophic action of ACTH and insulin upon adrenocortical enzymes of the squaliform elasmobranch Ginglymostoma cirratum (Bonnaterre). (1976) (3)
Effect of environmental temperature upon rates and duration of hemolysis of squaliform erythrocytes (1977) (3)
Platelets: “First Responders” in Cancer Progression and Metastasis (2017) (3)
Effect of 12-HETE on the Expression of Autocrine Motility Factor-Receptor and Motility in Melanoma Cells (1993) (3)
Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism. (1987) (3)
Proteinase and inhibited by prostacyclin. (1982) (2)
Activation of a cathepsin B-like latent enzyme from cultures of murine B16 amelanotic melanoma (1984) (2)
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations. (1996) (2)
Adhesion molecules and tumor cell-vasculature interactions: modulation by bioactive lipid molecules. (1996) (2)
Mechanism of ACTH action in the crocodilian adrenal (Caiman sclerops) (1974) (2)
Recessive oncogenes: Current status (2008) (2)
Heterogeneous Expression of Proangiogenic and Coagulation Proteins in Gliomas of Different Histopathological Grade (2021) (2)
Eicosanoids regulation of transcription factors in PC-3 prostate cancer cells. (2002) (2)
Activation Of Protein Kinase C by 12(S)-HETE: Role in Tumor Cell Metastasis (1993) (2)
Fatty Acid Modulation of Cancer Cell Spreading and Cytoskeleton Rearrangement (1993) (2)
Intracellular distribution, activity, and Ca(2+)-dependent translocation of 12-lipoxygenase in Lewis lung tumor cells. (1997) (2)
Chapter 5 Molecular biology of prostate cancer: Tumor Suppressor Genes (1999) (2)
Direct prostaglandin effects upon cortisol production by bovine adrenal mitochondria (1978) (1)
Synthesis of Peptide‐Diazeniumdiolate Conjugates: Towards Enzyme Activated Antitumor Agents. (2001) (1)
Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma (2004) (1)
Is depression the missing link between inflammatory mediators and cancer? (2022) (1)
The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection (2022) (1)
Chapter 7 Angiogenesis in prostate cancer (1999) (1)
Chapter 6 Apoptosis and prostate cancer (1999) (1)
Effects of prostaglandins possessing an alpha,beta-unsaturated carbonyl on tumor growth and differentiation. (1985) (1)
Role of Eicosanoids in Tumor Cell-Platelet-Endothelial Cell Interactions (1987) (1)
PURIFICATION AND CHARACTERIZATION OF TWO PROCOAGULANTS FROM WALKER 256 CARCINOSARCOMA TUMORS, (1987) (1)
Abstract 3483: Activation of thromboxane A2 receptor-alpha promotes tumor growth and angiogenesis through expression of VEGF in prostate cancer (2011) (1)
Specialized pro-resolving mediators reduce pro-nociceptive inflammatory mediator production in models of localized provoked vulvodynia. (2021) (1)
Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past? (2017) (1)
Metastasis from metastases an animal model (1985) (1)
The effect of prostaglandins on 11-beta hydroxylase activity in bovine adrenocortical mitochondria. (1980) (1)
12(S)-hete regulation of nuclear factor kappa B in PC-3 prostate cancer cells (1999) (0)
And thromboxane b2 upon melanoma cell dna synthesis. Abstr. (1979) (0)
Platelets and cancer: a casual or causal relationship: revisited (2014) (0)
In vitro cAMP, aldosterone and cortisol responses of adult human adrenocortical tissue to ACTH and human growth hormone (1977) (0)
Inhibition of tumor cell growth by prostaglandins of the a series. Abstr. (1981) (0)
Methods and compositions for the treatment of tumors with content of a calcium-channel blocker compound from the class of dihydropyridines and a platinum coordination compound. (1986) (0)
Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry (2023) (0)
Effects of prostaglandin endoperoxides prostaglandins and thromboxane B upon melanoma cell DNA synthesis (1979) (0)
Arachidonic acid metabolism as a target for antimetastatic agents (1984) (0)
Instructions for Authors (2004) (0)
Induces Microvascular Endothelial Cell Retraction )-Hydroxyeicosatetraenoic Acid S Tumor Cell-derived 12 ( Updated (2007) (0)
in Acute Lung Injury and Pulmonary Fibrosis Human lung ﬁbroblasts produce proresolving peroxisome proliferator-activated receptor- (cid:2) ligands in a cyclooxygenase-2-dependent manner (2016) (0)
CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS SYNERGISTICALLY MODULATE TUMOR CELL INDUCED PLATELET AGGREGATION (1987) (0)
Potential use of prostaglandins A1 and A2 in cancer chemotherapy (1979) (0)
12-lipoxygenase Eicosanoid regulation of angiogenesis: role of endothelial arachidonate (2013) (0)
ROLE OF PLATELET GLYCOPROTEINS lb AND llb/llla IN TUMOR CELL INDUCED PLATELET AGGREGATION AND TUMOR CELL ADHESION TO EXTRACELLULAR MATRIX. I. Grossi (1987) (0)
Abstract 2902: Phosphorylation of 12 lipoxygenase at Tyrosines 19 and 614 regulates its activity during beta4 integrin signaling (2011) (0)
Prostate cancer old problems and new approaches (1996) (0)
Arachidonate 12-lipoxygenase stimulates tumor angiogenesis by upregulation of vascular endothelial growth factor expression (1999) (0)
Antagonistic action of E and F series prostaglandins upon mineralocorticoid production by the human adrenal (1977) (0)
Abstract 2890: A novel interaction between 12-lipoxygenase and integrin subunit Beta4 plays a role in tumor migration, invasion and metastasis (2011) (0)
Physical interaction with B4 integrin regulates arachidonate 12-lipoxygenase activity (1999) (0)
It is not just the drugs that matter: the nocebo effect (2019) (0)
Characterization of a Novel 12(S)-HETE Receptor and its Role in Prostate Cancer Progression (2008) (0)
Special Tribute in Memoriam. (2021) (0)
Work accomplishments—Isaiah J. Fidler (2007) (0)
Abstract 5124: 12-Lipoxygenase regulation of prostate cancer progression. (2013) (0)
Effects of A and B prostaglandins on cAMP, cortisol, and aldosterone production by the human adrenal. (1977) (0)
Special issue - Prostate cancer: Basic and translational research. Preface (2001) (0)
Fatty Acyl Lipidomic Changes Converge Towards Increased Inflammation with Severity of COVID-19 (2021) (0)
Radiation Enhances Tumor Cell Metastasis (1993) (0)
Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner (2015) (0)
Thromboxane A2 regulation of angiogenesis and tumor metastasis (1999) (0)
Instruction for Authors (1975) (0)
Aryl aliphatic acids (1993) (0)
Platelets and cancer angiogenesis nexus (2017) (0)
Medication containing 3-methyl-1- (2- (2-naphthyloxy) -ethyl) -2-pyrazolin-5-one for the reduction of metastasis (1982) (0)
Integrin Expression in Tumor Progression — Role of Signaling Mechanisms (2017) (0)
リポキシゲナーゼ代謝産物12(S)-HETEは毛細血管内皮細胞のプロテインキナーゼC依存性細胞骨格再構成と退縮を誘導する (1993) (0)
Temporal effects of ACTH, indomethacin and 7-oxa-13-prostynoic acid upon glucocorticoid production by the human adrenal (1977) (0)
Blockade of NF-kappa B sensitizes prostate cancer cells to ionizing radiation (2004) (0)
Transformation of Exogenous Arachidonic Acid into a New Metabolite, 12-Keto- 5,8,10,14-Eicosatetraenoic Acid by Lewis Lung Carcinoma Cells: Implications in Tumor Cell Metastasis (1993) (0)
Award Number: W81XWH-06-1-0226 TITLE: Characterization of a Novel 12(S)-HETE Receptor and its Role in Prostate Cancer Progression (2008) (0)
Arachidonic acid metabolites regulation of tumor cell proliferation (1980) (0)
POLM 2020 Special Issue Preface. (2021) (0)
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective (2022) (0)
Phase I "Bioactive Lipids: Role in Prostate Cancer Angiogenesis" (2000) (0)
Cigarette Smoking Impairs Resolution of Inflammation Which Contributes to Susceptibility to Lung Infection (2020) (0)
Instructions for Authors (2004) (0)
P16 14 MP – LOW LEVEL RADIATION ALTERS TUMOR CELL METASTATIC PHENOTYPE (1991) (0)
Editorial (2013) (0)
Chemical Mechanisms of Modulation of Tumor Growth and Metastasis by Prostaglandins (1986) (0)
Agricultural and environmental management with raman spectroscopy (2015) (0)
Bioactive Lipids: Role in Prostate Cancer Angiogenesis (1999) (0)
Tyrosine phosphorylation of a ∼30 kd protein precedes αvβ3 integrin-signaled endothelial cell spreading and motility on matrix proteins (2008) (0)
Cathespin b-like proteinase identified as inducer of platelet aggregation by tumor cells. Abstr. (1982) (0)
PROSTACYCLIN: A POTENT ANTIMETASTATIC AGENT (1981) (0)
Eicosanoid Regulation of Prostate Cancer Progression: Disruption of Hemidesmosomes and Collaboration in Tumor Invasive Growth (2004) (0)
Platelet “first responders” in wound response, cancer, and metastasis (2017) (0)
Advances in Brief Autocrine Motility Factor Induces Differential 12-Lipoxygenase Expression and Activity in High-and Low-Metastatic K 1735 Melanoma Cell Variants ' (2006) (0)
Dual Regulatory Role of Cyclooxygenase and Lipoxygenase and their Products in Cell Survival and Apoptosis (1996) (0)
Phase II clinical trial of zileuton in persons with bronchial dysplasia (2007) (0)
Enhanced Membrane Expression Of Cytoadhesion αIIbβ3 in Lewis Lung Carcinoma Cells by Epoxyeicosatrienoic Acids (1993) (0)
Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis (2015) (0)
In vitro response of shark (Ginglymostoma cirratum) thyroid to TSH following cold acclimation (1978) (0)
Dr. Fidler, I.J.—Forty years of metastasis research (2007) (0)
Update on eicosanoids and prostate cancer (1999) (0)
Calcium channel blockers (CCBs) decrease chemotaxis in ovarian cancer cells (1987) (0)
Inhibition of lipoxygenase-mediated lysosomal cathepsin b release from tumor cells by nafazatrom. Abstr. (1982) (0)
Multiple signaling pathways lead to the activation of ERK BY12(S)-HETE (1999) (0)
Mechanisms of Cancer Metastasis: Potential Therapeutic Implications (2011) (0)
Instructions for Authors (2004) (0)
Introduction. (2019) (0)
12(S)-HETE Binding studies indicate the existence of several binding sites possession different affinities toward the ligand (1995) (0)
3rd European Meeting on Vascular Biology and Medicine: pp II/43–II/51 (2005) (0)
Special Tribute in Memoriam. (2021) (0)
12-Lipoxygenase in hypoxia and hypoxia-induced angiogenesis. (2004) (0)
Professor Lina M. Obeid (1955–2019) (2019) (0)
Late abstracts 186–187 (2005) (0)
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners (2021) (0)
Interaction of 12-lipoxygenase with cellular proteins (1999) (0)
Effects of prostaglandins (PG) possessing an α-β unsaturated carbonyl on tumor growth and differentiation (1985) (0)
Thromboxane Synthase and Prostate Cancer Progression (2004) (0)
Erratum to Dome et al., “Parallel expression of IIb3 and v3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype.” Int J Cancer 2005; 116:25–35 (2006) (0)
Bioactive lipid metabolism in platelet “first responder” and cancer biology (2018) (0)
mRNA in murine tumors (1989) (0)
Nafazatrom (bay g 6575): inhibition of tumor cell proliferation and metastasis. Abstr. (1982) (0)
Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis (2016) (0)
Chapter 10 Integrins in prostate cancer metastasis (1999) (0)
Advances in Experimental Medicine and Biology: Preface (2000) (0)
Chapter 4 Tumor markers for prostate cancer (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kenneth V. Honn?

Kenneth V. Honn is affiliated with the following schools:

Wayne State University